Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In

Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice — DELTA

Controlled Ovarian Stimulation Clinical Trial

Official title:
French Prospective Multicentre Non-Interventional Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice

Status Completed

Clinical Trial Summary

The aim of the study is to explore how the individualized dosing regimen of REKOVELLE is used in routine clinical practice and to describe the effectiveness and safety of REKOVELLE under real-world conditions.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Controlled Ovarian Stimulation

Clinical Trial Details

NCT number	NCT04503707
Study type	Observational
Source	Ferring Pharmaceuticals
Contact
Status	Completed
Phase
Start date	June 17, 2020
Completion date	October 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04122729` - N680S Polymorphism of the FSHR Gene and Its Relationship With the Type of Gonadotropin Used in COS
Terminated	`NCT03697031` - Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE®
Completed	`NCT03051087` - To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran®	Phase 4
Completed	`NCT01339299` - Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART)	Phase 4
Completed	`NCT03366025` - Progesterone Variation on the Final Day of Oocyte Maturation.
Completed	`NCT00725491` - A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)	Phase 3
Completed	`NCT03564509` - A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.	Phase 2
Completed	`NCT03393780` - Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures
Withdrawn	`NCT01510054` - Endometrial Luteal Phase Characteristics and Luteal Phase Support in Controlled Ovarian Stimulation Protocols With GnRH Antagonists:Focusing on MicroRNA	N/A
Completed	`NCT00988260` - Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED)	Phase 2
Completed	`NCT05499052` - Trial to Assess the Pattern of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation (IVF) or Intracytoplasmic Sperm Injection (ICSI) Procedures in Routine Clinical Practice